nandrolone

The solution was injected rapidly (in approximately 10 ml of 1.5 sec). Aortography: 30-50 ml intraaortic 76% solution at a rate of 8 ml / s. Digitalnaya (digital) arteriography:administered 60% solution in an amount corresponding to the magnitude bloodstream surveyed artery. Angiocardiography : administered 60 ml of 76% solution at a rate of 8 ml / s. splenoportography:administered 76 ml of 20-30% solutionnandrolone at 8 ml / s. The study of the urinary tract. Preparation of the patient to the study: one day before the study the patient’s food ration should not contain foods that cause fermentation and flatulence. It is recommended to exclude from the diet of dairy products, fruit, vegetables, salads, smoked, coarse black or freshly baked bread. The night before and the morning of the study – cleansing enemas. Immediately before the test is necessary to empty the bladder. Research carried out on an empty stomach. Excretory urography: 20-40 ml of 60% solution, heated to body temperature, is introduced slowly into the cubital vein. For the unprepared (without cleansing enema) or obese patients is better to use 76% solution in the same amount. At reduced renal function is introduced into / in the drip, diluted in 250-300 ml of 5% glucose, for 5-10 minutes.

 

Special instructions.

Since nandroloneis an iodine-containing drug, a small amount of it can be absorbed by the thyroid gland. After applying  radioisotope study of the thyroid gland is not informative.
If there is a history of allergies (hay fever, asthma, drug and food allergies, allergodermatoses) should take into account the possibility of increased sensitivity to contrast media and conduct premedication with antihistamines.
In case of itching, hives, runny nose, swelling, a sharp decline in blood pressure, tachycardia, bronchospasm, and other manifestations of hypersensitivity use of the drug is contraindicated.
When stored in the cold part of the active substance in the capsules might crystallize. The crystals were dissolved by dipping vial for a few minutes in hot water or heating in a boiling water bath. If the crystals disappear and the solution becomes clear, and upon cooling to 33-36 ° C the crystals fall out again, then the solution is usable.

Overdose.

In case of overdose nandrolone can be removed from the body by extracorporeal dialysis.

Side effect.

Systemic reactions: fever, dizziness, headache, nausea, vomiting, cyanosis, tearing, itching, erythematous rash, urticaria, bronchospasm, angioedema, anaphylactoid reactions, pulmonary edema, anaphylactic shock, hypotension, neurological disorders, diarrhea, exacerbation of enteritis or colitis, acute renal failure. Rarely – cramps. Local reactions: . Soreness at the injection site, phlebitis, thrombosis. Adverse reactions with certain types of research . Ventricular fibrillation of the heart – may occur when the coronary and angiokardiografii attack of angina – may occur when coronary angiography, left ventriculography. Cardiac arrhythmias – extrasystoles, arrhythmia, tachycardia may be caused by the contrast of the heart and coronary arteries.

 

Interaction with other drugs.

Patients taking beta-blockers, symptoms of anaphylaxis when using the drug may be atypical and mistaken for vagal reaction. Using  in patients with diabetic nephropathy, taking biguanides (metformin), can lead to a transient disturbance of kidney function and the development of lactic acidosis. As a precaution, biguanides should be stopped reception for 48 hours prior to the study and resume after complete stabilization of kidney function.
Mixed in the same syringe with other drugs, since it is possible change of pharmacological and physicochemical properties of drugs.

Application of pregnancy and during breastfeeding.

Do not use this drug during pregnancy or breastfeeding.

Ability to influence the reaction rate when driving and other mechanisms .

It is undesirable to drive a car or operate moving mechanisms within the first 24 hours after the study.

Product form.

Injectable nandroloneampoule of colorless glass ring or without the ring fracture.
For 5 or 10 vials together with instructions for medical use and knife ampulnam ceramic or disc cutter ceramic is placed in a pile of cardboard.
For five ampules (a break ring) is placed in blister. On 1 or 2 blisters with instruction on the medical application put in a pile of cardboard.